Natural Resources Defense Council, Inc. et al v. United States Food and Drug Administration et al
Filing
60
ANSWER to 53 Amended Complaint,. Document filed by Center for Veterinary Medicine, Bernadette Dunham, Margaret Hamburg, Kathleen Sebelius, United States Department of Health and Human Services, United States Food and Drug Administration.(Barcelo, Amy)
UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF NEW YORK
____________________________________
)
NATURAL RESOURCES DEFENSE
)
COUNCIL, et al.,
)
)
Plaintiffs,
)
ANSWER TO FIRST SUPPLEMENTAL
)
COMPLAINT
v.
)
11 CIV 3562 (THK)
)
UNITED STATES FOOD AND DRUG
)
ECF CASE
ADMINISTRATION, et al.,
)
)
Defendants.
)
____________________________________)
Defendants, the United States Food and Drug Administration (“FDA”); Margaret
Hamburg, in her official capacity as Commissioner of Food and Drugs; Center for Veterinary
Medicine; Bernadette Dunham, in her official capacity as Director, Center for Veterinary
Medicine; United States Department of Health and Human Services; and Kathleen Sebelius, in
her official capacity as Secretary, United States Department of Health and Human Services
(collectively, the “Defendants”), by their attorney, Preet Bharara, United States Attorney for the
Southern District of New York, answer the First Supplemental Complaint for Declaratory and
Injunctive Relief (the “Supplemental Complaint”) of plaintiffs Natural Resources Defense
Council, Inc., Center for Science in the Public Interest, Food Animal Concerns Trust, Public
Citizen, Inc., and Union of Concerned Scientists, Inc. (“Plaintiffs”) upon information and belief
as follows:
1.
The first sentence of paragraph 1 of the Supplemental Complaint constitutes
Plaintiffs’ characterization of their claims and a legal conclusion of Plaintiffs as to which no
answer is required. To the extent a response is required, Defendants deny the allegations
contained in that sentence. In response to the second sentence of this paragraph, Defendants
reassert and incorporate by reference herein each of their responses to Plaintiffs’ First Amended
Complaint for Declaratory and Injunctive Relief (“Amended Complaint”).
2.
The first sentence of paragraph 2 of the Supplemental Complaint states the legal
opinion and conclusions of Plaintiff as to which no answer is required. To the extent that an
answer to these allegations is required, Defendants admit that this sentence purports to describe a
provision contained in the Federal Food, Drug, and Cosmetic Act (“FFDCA”), and respectfully
refer the Court to the cited statutory provision for a correct and complete statement of its
contents. Defendants admit the remainder of the allegations contained in paragraph 2 of the
Supplemental Complaint.
3.
With respect to the first sentence of paragraph 3 of the Supplemental Complaint,
Defendants admit that FDA issued tentative responses to the Petitions soon after they were filed,
and that final responses were issued on November 7, 2011 (“Responses”). The allegations in the
second and fourth sentences are admitted. The third sentence contains a characterization of
FDA’s statements in the Responses, and Defendants respectfully refer the Court to the Responses
for a correct and complete statement of their contents.
4.
Defendants deny the allegations contained in paragraph 4 of the Supplemental
Complaint.
5.
Paragraph 5 of the Supplemental Complaint consists of Plaintiffs’ characterization
of the Supplemental Complaint, as to which no answer is required. To the extent that an answer
to this paragraph is required, Defendants admit that Plaintiffs purport to seek the requested relief,
but deny that they are entitled to it.
6.
Paragraph 6 of the Supplemental Complaint states the legal opinions and
conclusions of the Plaintiffs, including citations to legal authority, as to which no answer is
2
required. To the extent that this paragraph contains factual allegations that may require an
answer, the Defendants deny all such allegations.
7.
Paragraph 7 of the Supplemental Complaint states the legal opinions and
conclusions of the Plaintiffs, including citations to legal authority, as to which no answer is
required. To the extent that this paragraph contains factual allegations that may require an
answer, the Defendants deny all such allegations.
8.
Paragraph 8 of the Supplemental Complaint states the legal opinions and
conclusions of the Plaintiffs, including citations to legal authority, as to which no answer is
required. To the extent that an answer to this paragraph is required, Defendants admit that
Plaintiffs purport to seek the requested relief, but deny that they are entitled to it.
9.
Paragraph 9 of the Supplemental Complaint states the legal opinions and
conclusions of the Plaintiffs, including citations to legal authority, as to which no answer is
required. To the extent that an answer is required, Defendants admit that the Commissioner of
Food and Drug is primarily responsible for implementing the FFDCA, and that antibiotics used
in animal feed may qualify under the FFDCA as “new animal drugs” when the requisite criteria
are satisfied, and otherwise deny the allegations in this paragraph.
10.
Paragraph 10 of the Supplemental Complaint states the legal opinion and
conclusions of Plaintiffs, including a citation to legal authority, as to which no answer is
required. To the extent that an answer to these allegations is required, Defendants admit that this
paragraph purports to describe provisions contained in the FFDCA and respectfully refer the
Court to the cited statutory provisions for a correct and complete statement of their contents.
11.
Defendants admit the allegations contained in paragraph 11 of the Supplemental
Complaint.
3
12.
Defendants admit the allegations contained in paragraph 12 of the Supplemental
Complaint.
13.
Defendants admit the allegations contained in paragraph 13 of the Supplemental
Complaint.
14.
Defendants admit the allegations contained in paragraph 14 of the Supplemental
Complaint.
15.
Defendants admit the allegations contained in paragraph 15 of the Supplemental
Complaint.
16.
Defendants admit that the statement quoted in the first sentence of paragraph 16 of
the Supplemental Complaint was made by the Department of Health and Human Services
(“HHS”) Office of Inspector General and represented the tentative position of HHS in the form
of comments on a draft GAO report, but deny that this statement constituted a final “conclusion”
of HHS. Defendants admit on information and belief that the remaining statements by the
Centers for Disease Control (“CDC”) were made in a letter from CDC to the Honorable Frank
Pallone, Jr. dated July 13, 2010.
17.
Defendants admit that the statement quoted in paragraph 17 of the Supplemental
Complaint was made by FDA’s Center for Veterinary Medicine, and otherwise deny the
allegations contained in this paragraph.
18.
Paragraph 18 of the Supplemental Complaint states the legal opinions and
conclusions of the Plaintiffs, as to which no answer is required. To the extent that paragraph 18
of the Supplemental Complaint contains factual allegations that may require an answer,
Defendants admit that FDA issued tentative responses to the Petitions soon after they were filed,
and that the Responses were issued on November 7, 2011.
4
19.
Paragraph 19 of the Supplemental Complaint consists of Plaintiffs’ characterization
of the Amended Complaint, as to which no answer is required. To the extent that an answer to
this paragraph is required, Defendants admit that Plaintiffs originally filed this action on May 25,
2011, and that Plaintiffs alleged in both their original complaint and the Amended Complaint
that FDA’s Responses to the Petitions were unreasonably delayed and otherwise deny the
allegations in this paragraph.
20.
Defendants admit the allegations contained in paragraph 20 of the Supplemental
Complaint.
21.
Defendants admit the allegations contained in paragraph 21 of the Supplemental
Complaint.
22.
Defendants admit the allegations contained in paragraph 22 of the Supplemental
Complaint.
23.
Defendants admit the allegations contained in paragraph 23 of the Supplemental
Complaint.
24.
Defendants admit the allegations contained in paragraph 24 of the Supplemental
Complaint.
25.
Defendants admit the statements contained in paragraph 25 of the Supplemental
Complaint are attributable to FDA, but deny that they were made “without supporting evidence.”
26.
Defendants deny the allegations contained in paragraph 26 of the Supplemental
Complaint.
27.
Defendants admit that the use of antibiotics in livestock may encourage the
emergence of antibiotic-resistant bacteria, and otherwise deny the allegations contained in
paragraph 27 of the Supplemental Complaint.
5
28.
Defendants admit the allegations contained in paragraph 28 of the Supplemental
Complaint.
29.
Defendants admit the allegations contained in paragraph 29 of the Supplemental
Complaint.
30.
Defendants admit the allegations contained in paragraph 30 of the Supplemental
Complaint.
31.
Defendants deny knowledge or information sufficient to form a belief as to the
truth or falsity of the allegations set forth in paragraph 31 of the Supplemental Complaint.
32.
Defendants deny the allegations contained in paragraph 32 of the Supplemental
Complaint.
33.
Defendants deny knowledge or information sufficient to form a belief as to the
truth or falsity of the allegations set forth in paragraph 33 of the Supplemental Complaint.
34.
Defendants reassert and incorporate by reference herein each of their responses to
the Amended Complaint and to Paragraphs 1 through 33 of the Supplemental Complaint as
though set forth fully herein.
35.
Paragraph 35 of the Supplemental Complaint states the legal opinions and
conclusions of the Plaintiffs, including citations to legal authority, as to which no answer is
required. To the extent that this paragraph contains factual allegations that may require an
answer, the Defendants deny all such allegations.
36.
Defendants deny the allegations contained in paragraph 36 of the Supplemental
Complaint.
37.
Defendants deny the allegations contained in paragraph 37 of the Supplemental
Complaint.
6
38.
Defendants deny the allegations contained in paragraph 38 of the Supplemental
Complaint.
The remainder of the allegations in the Supplemental Complaint constitute a prayer for
relief, to which no response is required. To the extent an answer is required, Defendants deny
that Plaintiffs are entitled to the relief requested therein or to any relief whatsoever.
All allegations not specifically admitted or denied in the foregoing numbered responses
are hereby denied.
AFFIRMATIVE DEFENSES
FIRST DEFENSE
The Supplemental Complaint should be dismissed in whole or in part for failure to state a
claim upon which relief can be granted.
SECOND DEFENSE
The Supplemental Complaint should be dismissed in whole or in part on the ground that
no subject matter jurisdiction exists over their claims.
Dated: New York, New York
February 21, 2011
Respectfully submitted,
PREET BHARARA
United States Attorney
Southern District of New York
/s/ Amy A. Barcelo_________
By: AMY A. BARCELO
Assistant United States Attorney
86 Chambers Street
New York, New York 10007
Tel.: (212) 637-6559
Fax: (212) 637-2730
Email: amy.barcelo@usdoj.gov
7
OF COUNSEL:
DAVID J. HOROWITZ
Deputy General Counsel
ELIZABETH H. DICKINSON
Acting Chief Counsel
ERIC M. BLUMBERG
Deputy Chief Counsel, Litigation
THOMAS J. COSGROVE
Associate Chief Counsel
U.S. Department of Health and Human Services
Office of the General Counsel, Food and Drug Administration
White Oak 31 Room 4331
10903 New Hampshire Avenue
Silver Spring, MD 20993-0002
(Tel): (301) 796-8613
8
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?